Ambys touts research, opens cell therapy manufacturing facility Cell and gene therapy developer Ambys Medicines presented new data on its bioreactor manufacturing platform at the IXA-CTRMS-2021 Virtual Congress on September 25. The company has also opened its current good manufacturing practices cell therapy manufacturing facility.Read More
L7 inks deal with ATCC L7 Informatics has signed an agreement with the American Type Culture Collection (ATCC) to enhance the digitalization of its manufacturing and laboratory operations.Read More
Everest Medicines, AbCellera ink multiyear deal Everest Medicines and AbCellera have entered into a multiyear collaboration and license agreement to discover therapeutic antibodies for up to 10 targets that will be selected by Everest. The initial programs will focus on targets in oncology, Everest said.Read More
Quinten Health, Aetion partner on AI for research studies Artificial intelligence (AI) developer Quinten Health and Aetion, a real-world evidence technology provider, have formed a strategic partnership to offer an integrated range of products and services.Read More
STM working group to address image alterations, duplication The International Association of Scientific, Technical and Medical Publishers (STM) has appointed a working group -- the Standards and Technology Committee (STEC) -- to answer questions about automatic image alteration and duplication detection in scholarly publications.Read More